tiprankstipranks
Trending News
More News >
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market

Acura Pharmaceuticals (ACUR) Income Statement

Compare
83 Followers

Acura Pharmaceuticals Income Statement

Last quarter (Q4 2021), Acura Pharmaceuticals's total revenue was $36.00K, a decrease of -94.99% from the same quarter last year. In Q4, Acura Pharmaceuticals's net income was $29.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.56M$ 3.57M$ 2.66M$ 410.00K$ 2.97M
Gross Profit
$ 352.00K$ 3.57M$ 2.65M$ 408.24K$ 2.84M
Operating Expenses
$ 1.25M$ 4.33M$ 3.38M$ 4.33M$ 8.06M
Depreciation and Amortization
$ 90.00K$ 125.00K$ 273.00K$ 280.00K$ 294.00K
EBITDA
$ -589.00K$ -633.00K$ -3.04M$ -3.17M$ -4.93M
Operating Income
$ -1.21M$ -758.00K$ -725.00K$ -3.92M$ -5.22M
Other Income/Expenses
$ 335.00K$ -450.00K$ -3.05M$ 73.00K$ -592.00K
Pretax Income
$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.82M
Net Income
$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.68M
Per Share Metrics
Basic EPS
$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Diluted EPS
$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Weighted Average Shares Outstanding
43.95M 30.20M 26.72M 21.15M 15.90M
Weighted Average Shares Outstanding (Diluted)
56.80M 32.32M 26.72M 21.15M 15.90M
Currency in USD

Acura Pharmaceuticals Earnings and Revenue History